Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Mingozzi

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
Blood|July 27, 2006
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyHaiyan Jiang, Linda B Couto, Susannah Patarroyo-White, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2012
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia BFederico Mingozzi, Yifeng Chen, Samuel L Murphy, et al.
Journal of Clinical Immunology|September 4, 2012
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunityLeslie P Cousens, Nader Najafian, Federico Mingozzi, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe MicePasqualina Colella, Pauline Sellier, Helena Costa Verdera, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia ABrian R Long, Philippe Veron, Klaudia Kuranda, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
A Quantitative <i>In Vitro</i> Potency Assay for Adeno-Associated Virus Vectors Encoding for the <i>UGT1A1</i> TransgeneSem J Aronson, Robert S Bakker, Sascha Moenis, et al.
Science Advances|October 27, 2021
A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemiaVolha V Zhukouskaya, Louisa Jauze, Séverine Charles, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
Blood|July 27, 2006
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyHaiyan Jiang, Linda B Couto, Susannah Patarroyo-White, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2012
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia BFederico Mingozzi, Yifeng Chen, Samuel L Murphy, et al.
Journal of Clinical Immunology|September 4, 2012
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunityLeslie P Cousens, Nader Najafian, Federico Mingozzi, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe MicePasqualina Colella, Pauline Sellier, Helena Costa Verdera, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia ABrian R Long, Philippe Veron, Klaudia Kuranda, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
A Quantitative <i>In Vitro</i> Potency Assay for Adeno-Associated Virus Vectors Encoding for the <i>UGT1A1</i> TransgeneSem J Aronson, Robert S Bakker, Sascha Moenis, et al.
Science Advances|October 27, 2021
A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemiaVolha V Zhukouskaya, Louisa Jauze, Séverine Charles, et al.
Pageof 14